Trial Profile
Pharmacokinetics and tolerability of fesoterodine vs tolterodine extended-release in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Apr 2011
Price :
$35
*
At a glance
- Drugs Fesoterodine; Tolterodine
- Indications Overactive bladder
- Focus Pharmacogenomic; Pharmacokinetics
- Sponsors Pfizer
- 25 Feb 2011 Results published in the British Journal of Clinical Pharmacology.
- 05 Nov 2010 New trial record.